A Review on: Digitalis Purpurea

  • Roshani Metkari Navsahyadri Institute of Pharmacy, Pune
  • Ashwini Markad Navsahyadri Institute of Pharmacy, Pune
  • Poonam Bhong Navsahyadri Institute of Pharmacy, Pune
  • Mohini Yadav Navsahyadri Institute of Pharmacy, Pune
  • Omkar Kolhe Navsahyadri Institute of Pharmacy, Pune
Keywords: CHF., Digitalis Purpurea L

Abstract

Digitalis contain cardiac glycosides and used in the treatment of congestive heart failure. Digitalis drug obtain from Digitalis Purpurea L. belongs to family scrophulariaceae. 200 years ago William Withering discover the use of digitalis in CHF treatment in 1785.In 18th century a controversy has existed about the benefits and risks of digitalis in patients with heart problems. Active component of digitalis classified as cardiac glycosides and cardiotonic steroids. The term "digitalis" or "cardiac glycosides" are used to refer to any of steroids or steroid glycosides compound which exert characteristic positively inotropic and electrophysiological effect on heart. In 20th century digitalis and its derivatives specially, digoxin is used in treatment of CHF. Cardiac glycosides are used in therapy of CHF since William Withering identify their uses. Digitalis purpurea is not only use in treatment of CHF also has wound healing, antioxidant and cytotoxic activity. In 1990 most prescribed drug is digoxin. It shows intermediate duration of action. Digoxin is use for its rate control in atrial fibrillation in the presence of marginal blood pressure. The introduction of diuretic provide an alternative more effective and safer for treatment of CHF.

Keywords: CHF., Digitalis Purpurea L

Published
2021-08-31
How to Cite
Metkari, R., Markad, A., Bhong, P., Yadav, M., & Kolhe, O. (2021). A Review on: Digitalis Purpurea. Journal of Biomedical and Pharmaceutical Research, 10(4). https://doi.org/10.32553/jbpr.v10i4.876
Section
Articles